FEFlavius Ebaisem Egbe

Flavius Ebaisem Egbe

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Flavius Ebaisem Egbe has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Prevalence and Factors Associated with Treatment Delay Among Colorectal Cancer Patients at Mulago National Referral Hospital and the Uganda Cancer Institute: A Cross-Sectional Study

    by Brian Kasagga, Paul Ssempebwa, Godfrey Kikuba, Flavius E. Egbe, Peace Caroline Nsodi, Joanne Kayaga, Paul Okeny, Emmanuel Alex Elobu

    Background Colorectal cancer (CRC) is an important cause of morbidity and mortality in Uganda. Timely treatment initiation is critical for outcomes, yet delays are common. This study assessed treatment delays and associated factors among CRC patients at Mulago National Referral Hospital (MNRH) and the Uganda Cancer Institute (UCI). Objective To determine the diagnosis to treatment interval (DTI), prevalence of treatment delay, and the associated patient and clinicopathologic factors among CRC patients. Methods A hospital-based cross-sectional study was conducted among 67 patients with histologically confirmed CRC between December 2024 and May 2025. Treatment delay was defined as > 31 days between histological diagnosis and first oncologic treatment. Data were collected through interviews and record review. Descriptive statistics summarized demographics and clinical characteristics. Bivariate Poisson regression with robust variance estimation identified factors associated with delay; variables with p < 0.20 entered a multivariable model. Prevalence ratios (PRs) with 95% confidence intervals (CIs) were reported. IRB approval was obtained (Ref: Mak-SOMREC-2024-1048). Results The mean age was 50.5 years (SD: 15.1); 55.2% were female, and 71.6% (n = 48) had advanced-stage disease (Stage III/IV). The median DTI was 53 days (IQR: 25–95), with 70.1% (n = 47) experiencing delays. Median DTI by treatment: chemotherapy 53 days, radiotherapy 79 days, surgery 14 days. While late-stage disease, comorbidities, and long travel distances showed trends toward delay, only socioeconomic status (SES) was significant. Patients with high SES vulnerability (score ≥ 4) had 34% higher prevalence of delay (PR = 1.34, 95% CI: 1.01–1.78, p = 0.042). Conclusion Most CRC patients experienced treatment delays which were widespread and occurred across all categories; regardless of distance to the treatment facility, clinical status, or disease severity. Socioeconomic disadvantage was the only independent predictor, underscoring the role of structural and financial barriers in timely care. Targeted, context-specific interventions are urgently needed to reduce delays and improve outcomes. Trial registration Not applicable

  • Open Access

    Effect of Perioperative Blood Transfusion on Complications Following Emergency Non-trauma Laparotomy in Mulago Hospital: A Prospective Cohort Study

    by Flavius E Egbe, Richard N. Iranya, Christian A Dimala, Ronald Mbiine, Michael Okello, Paul K. Okeny

    Background Although blood transfusion may be required during emergency non-trauma laparotomy, several retrospective cohort studies have identified blood transfusion as a significant predictor of postoperative infections and mortality. However, no study has explored such an association in a resource-limited setting. This study aims to determine the effect of perioperative blood transfusion on the 30-day risk of surgical site infections (SSIs) and mortality among patients undergoing emergency non-trauma laparotomy in a large urban tertiary hospital in a resource-limited setting. Methodology In this prospective, single-center, cohort study, we recruited 160 consecutive adult patients admitted to the general surgery wards 48 hours after emergency non-trauma laparotomy. We grouped them based on transfusion exposure status. Transfusion exposure and possible confounders were recorded on entry, while the presence or absence of SSIs and mortality were obtained over 30 days of follow-up. The data were analyzed using Epi Info version 7 and Stata version 14. P-values <0.05 indicated statistical significance. Results All 160 participants recruited, 28 (17.5%) transfusion-exposed and 132 (82.5%) non-exposed, were included in the final analysis. Transfusion exposure (relative risk = 8.16; 95% confidence interval (CI) = 2.73-24.37; p < 0.001) was an independent risk factor for SSI after multivariate logistic regression analysis adjusted for confounders. Inverse probability weighting with regression adjustment (IPWRA) revealed that transfusion exposure significantly increased the incidence of SSI by 36.2% (95% CI = 14.2%-58.2%; p = 0.001). Furthermore, transfusion exposure (hazard ratio (HR) = 3.62; 95% CI = 1.28-10.27; p = 0.015) and age ≥60 years (HR = 5.97; 95% CI = 1.98-18.01; p = 0.002) were independent risk factors for 30-day mortality after multivariate Cox regression analysis adjusted for confounders. IPWRA revealed that transfusion exposure significantly increased the incidence of mortality by 17.6% (95% CI = 1.4%-33.8%; p = 0.033). Conclusions This study suggests an independent association between perioperative blood transfusion and the occurrence of SSIs and mortality among patients undergoing emergency non-trauma laparotomy. A larger multicenter prospective cohort study considering more confounders and the use of established restrictive transfusion protocols is recommended.


  • Open Access

    Effect of perioperative blood transfusion on complications following emergency non-trauma laparotomy in Mulago hospital: A prospective cohort study.

    by Flavius Ebaisem Egbe, Ronald Mbiine, Michael Okello, Richard Newton Iranya, Paul Okeny

    Background: Blood transfusion may be required in the management of patients undergoing emergency non-trauma laparotomy. However, several retrospective cohort studies involving patients undergoing laparotomy for benign and malignant indications have identified blood transfusion as a significant predictor of postoperative infections and mortality. Still, no study has explored such an association in our setting. We aimed to determine the effect of perioperative blood transfusion on the 30-day risk of surgical site infections and mortality among patients undergoing emergency non-trauma laparotomy in a large urban tertiary hospital in a low-resource setting. Methods: In this prospective cohort study, we recruited 160 consecutive adult patients admitted to the general surgery wards 48 hours after emergency non-trauma laparotomy. We grouped them based on transfusion exposure status. Independent variables, including perioperative blood transfusion and confounders, were recorded on entry, while dependent variables, including the presence or absence of surgical site infection and mortality, were obtained over a 30-day follow-up period. The data were analysed using EPI INFO version 7, SPSS version 29, and Stata version 14; pResults: All 160 participants recruited, 28 (17.5%) transfused (exposed) and 132 (82.5%) not transfused (non-exposed), were included in the final analysis. Transfusion exposure (RR, 7.81; 95% CI, 2.58 – 23.63; p=0.0003) and preoperative leucocytosis/leukopenia (RR, 2.19; 95% CI, 1.04 – 4.65; p=0.040) were identified as independent risk factors for SSI after multivariate logistic regression analysis adjusted for confounders including preoperative anaemia, young-to-middle-aged adults, cloudy/purulent/feculent exudate, gut perforation diagnosis, female sex, and registrar-led surgical team. Furthermore, transfusion exposure (HR, 3.36; 95% CI, 1.11 – 10.25; p=0.033) and old age ≥60 years (HR, 5.50; 95% CI, 1.67 – 18.11; p=0.005) were identified as independent risk factors for 30-day mortality after multivariate Cox regression analysis adjusted for confounders including high ASA score, immunodeficiency, cloudy/purulent/feculent exudate, bowel obstruction and high-risk procedure for bowel leak. Conclusion: Among patients undergoing emergency non-trauma laparotomy, perioperative blood transfusion compared with no perioperative blood transfusion increased the 30-day risk of SSI by 7.81 and the 30-day mortality risk by 3.36. A restrictive transfusion strategy and a more extensive multicentre prospective cohort study are recommended.


  • Open Access

    Adult-Onset Wilms Tumor: A Case Report

    by Flavius E. Egbe, Dan Namuguzi, Joseph Masaba, Philip Babua, Hope Kibansha Matumaini

    Background:Wilms tumor or nephroblastoma is the most common pediatric renal malignancy. However, the presentation of the adult variant of this tumor is rare, especially in our low-resource setting where there is a diagnostic challenge. This tumor is often missed, resulting in a poorer prognosis than that associated with the childhood variants. We present the case of a young adult with a Wilms tumor who was initially diagnosed with renal cell carcinoma. Case presentation: This is the case of an eighteen-year-old boy who presented with a prolonged history of progressive painful left flank fullness, hematuria, low-grade fever, nausea/vomiting, and weight loss in whom examination also revealed hypertension, a tender left flank mass, and left varicocele. Abdominal/chest CT suggested a malignant tumor in the left kidney with inferior vena cava thrombosis, para-aortic lymph node involvement, and lung metastasis presumed to be renal cell carcinoma. Following radical left nephrectomy and histopathological examination, a final diagnosis of stage IV left blastemal-type Wilms tumor was made. The patient was discharged on postoperative day nine and referred for adjuvant chemotherapy and localized radiotherapy to the lung and left flank area. However, he died several weeks after surgery without adjuvant therapy after being lost to follow-up. Conclusion:This report aims to alert clinicians of adult-onset Wilms tumor when an adult presents with a flank mass especially as this is a rare condition. This should allow for early diagnosis and expeditious management of this disease variant.